ESMO

News

New guidance covers AI-based biomarkers for cancer care

ESMO guidance on the validation and clinical use of AI-based biomarkers in oncology aims to strike a balance between caution and over-reliance.

Oncology

Pre-ESMO insights: Corcept on platinum-resistant ovarian can...

pharmaphorum speaks with Corcept Therapeutics about its presentation of data in platinum-resistant ovarian cancer at both ASCO and ahead of ESMO 2025.

Oncology

Lung cancer lung disease 3d illustration

Innovation, real-world data, and precision medicine: Pierre ...

Ahead of ASCO 2025, Pierre Fabre charts bold progress in NSCLC with targeted therapies, real-world data, and innovative partnerships

Oncology

Inside ESMO 2024: Treatments, trials, and top HCPs on social...

Discover the latest treatments, clinical trials, and top healthcare professionals sharing insights on social media from the ESMO 2024 conference.

Oncology

Dr Meredith McKean interview with Nicole Raleigh

ESMO 2024 – Dr Meredith McKean

In our final video from ESMO 2024, web editor Nicole Raleigh spoke with Dr Meredith McKean, a melanoma investigator at the Sarah Cannon Research Institute.

Oncology

ESMO 2024 Dr Magda Meissner interview with Nicole Raleigh

ESMO 2024 – Magda Meissner

In our penultimate video from ESMO 2024, pharmaphorum spoke with Dr Magda Meissner, consultant medical oncologist at the Velindre Cancer Centre and project lead for QuicDNA, about how a sim

New guidance covers AI-based biomarkers for cancer care

Pre-ESMO insights: Corcept on platinum-resistant ovarian can...

Innovation, real-world data, and precision medicine: Pierre ...

Inside ESMO 2024: Treatments, trials, and top HCPs on social...

ESMO 2024 – Dr Meredith McKean

ESMO 2024 – Magda Meissner

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

ESMO

Editor's Picks